enVVeno Medical is a medical device company developing tissue based solutions that are designed to be life sustaining or life improving for patients with cardiovascular disease, and peripheral arterial and venous disease. Co.'s two main products which it is developing are: the VenoValve®, a porcine based device to be surgically implanted in the deep venous system of the leg to treat a debilitating condition called chronic venous insufficiency; and the CoreoGraft®, a bovine based conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The NVNO stock yearly return is shown above.
The yearly return on the NVNO stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2021 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the NVNO annual return calculation with any dividends reinvested as applicable (on ex-dates).
|